eF-site ID 6ne5-ABCD
PDB Code 6ne5
Chain A, B, C, D

click to enlarge
Title Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors that Demonstrate in vivo Activity in Mouse Xenograft Models of Human Cancer
Classification APOPTOSIS
Compound Induced myeloid leukemia cell differentiation protein Mcl-1
Source (MCL1_HUMAN)
Sequence A:  DELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALE
TLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMI
HVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLA
ESITDVLVRTKRDWLVKQRGWDGFVEFFHVE
B:  DELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALE
TLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMI
HVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLA
ESITDVLVRTKRDWLVKQRGWDGFVEFFHVE
C:  DELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALE
TLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMI
HVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLA
ESITDVLVRTKRDWLVKQRGWDGFVEFFHV
D:  DELYRQSLEIISRYLREQATGAKDTKPMSGATSRKALETL
RRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHV
FSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAES
ITDVLVRTKRDWLVKQRGWDGFVEFFHV
Description


Functional site

1) chain A
residue 224
type
sequence H
description binding site for residue KJP A 400
source : AC1

2) chain A
residue 227
type
sequence A
description binding site for residue KJP A 400
source : AC1

3) chain A
residue 228
type
sequence F
description binding site for residue KJP A 400
source : AC1

4) chain A
residue 231
type
sequence M
description binding site for residue KJP A 400
source : AC1

5) chain A
residue 249
type
sequence V
description binding site for residue KJP A 400
source : AC1

6) chain A
residue 250
type
sequence M
description binding site for residue KJP A 400
source : AC1

7) chain A
residue 253
type
sequence V
description binding site for residue KJP A 400
source : AC1

8) chain A
residue 254
type
sequence F
description binding site for residue KJP A 400
source : AC1

9) chain A
residue 256
type
sequence D
description binding site for residue KJP A 400
source : AC1

10) chain A
residue 258
type
sequence V
description binding site for residue KJP A 400
source : AC1

11) chain A
residue 260
type
sequence N
description binding site for residue KJP A 400
source : AC1

12) chain A
residue 263
type
sequence R
description binding site for residue KJP A 400
source : AC1

13) chain A
residue 267
type
sequence L
description binding site for residue KJP A 400
source : AC1

14) chain A
residue 270
type
sequence F
description binding site for residue KJP A 400
source : AC1

15) chain A
residue 271
type
sequence G
description binding site for residue KJP A 400
source : AC1

16) chain A
residue 294
type
sequence I
description binding site for residue KJP A 400
source : AC1

17) chain C
residue 320
type
sequence H
description binding site for residue KJP A 400
source : AC1

18) chain B
residue 227
type
sequence A
description binding site for residue KJP B 400
source : AC2

19) chain B
residue 228
type
sequence F
description binding site for residue KJP B 400
source : AC2

20) chain B
residue 231
type
sequence M
description binding site for residue KJP B 400
source : AC2

21) chain B
residue 246
type
sequence L
description binding site for residue KJP B 400
source : AC2

22) chain B
residue 250
type
sequence M
description binding site for residue KJP B 400
source : AC2

23) chain B
residue 253
type
sequence V
description binding site for residue KJP B 400
source : AC2

24) chain B
residue 254
type
sequence F
description binding site for residue KJP B 400
source : AC2

25) chain B
residue 258
type
sequence V
description binding site for residue KJP B 400
source : AC2

26) chain B
residue 260
type
sequence N
description binding site for residue KJP B 400
source : AC2

27) chain B
residue 262
type
sequence G
description binding site for residue KJP B 400
source : AC2

28) chain B
residue 263
type
sequence R
description binding site for residue KJP B 400
source : AC2

29) chain B
residue 267
type
sequence L
description binding site for residue KJP B 400
source : AC2

30) chain B
residue 270
type
sequence F
description binding site for residue KJP B 400
source : AC2

31) chain B
residue 271
type
sequence G
description binding site for residue KJP B 400
source : AC2

32) chain B
residue 294
type
sequence I
description binding site for residue KJP B 400
source : AC2

33) chain C
residue 224
type
sequence H
description binding site for residue KJP C 400
source : AC3

34) chain C
residue 227
type
sequence A
description binding site for residue KJP C 400
source : AC3

35) chain C
residue 228
type
sequence F
description binding site for residue KJP C 400
source : AC3

36) chain C
residue 231
type
sequence M
description binding site for residue KJP C 400
source : AC3

37) chain C
residue 250
type
sequence M
description binding site for residue KJP C 400
source : AC3

38) chain C
residue 253
type
sequence V
description binding site for residue KJP C 400
source : AC3

39) chain C
residue 254
type
sequence F
description binding site for residue KJP C 400
source : AC3

40) chain C
residue 256
type
sequence D
description binding site for residue KJP C 400
source : AC3

41) chain C
residue 258
type
sequence V
description binding site for residue KJP C 400
source : AC3

42) chain C
residue 260
type
sequence N
description binding site for residue KJP C 400
source : AC3

43) chain C
residue 262
type
sequence G
description binding site for residue KJP C 400
source : AC3

44) chain C
residue 263
type
sequence R
description binding site for residue KJP C 400
source : AC3

45) chain C
residue 267
type
sequence L
description binding site for residue KJP C 400
source : AC3

46) chain C
residue 270
type
sequence F
description binding site for residue KJP C 400
source : AC3

47) chain C
residue 271
type
sequence G
description binding site for residue KJP C 400
source : AC3

48) chain C
residue 294
type
sequence I
description binding site for residue KJP C 400
source : AC3

49) chain D
residue 227
type
sequence A
description binding site for residue KJP D 400
source : AC4

50) chain D
residue 228
type
sequence F
description binding site for residue KJP D 400
source : AC4

51) chain D
residue 231
type
sequence M
description binding site for residue KJP D 400
source : AC4

52) chain D
residue 246
type
sequence L
description binding site for residue KJP D 400
source : AC4

53) chain D
residue 250
type
sequence M
description binding site for residue KJP D 400
source : AC4

54) chain D
residue 253
type
sequence V
description binding site for residue KJP D 400
source : AC4

55) chain D
residue 254
type
sequence F
description binding site for residue KJP D 400
source : AC4

56) chain D
residue 258
type
sequence V
description binding site for residue KJP D 400
source : AC4

57) chain D
residue 260
type
sequence N
description binding site for residue KJP D 400
source : AC4

58) chain D
residue 262
type
sequence G
description binding site for residue KJP D 400
source : AC4

59) chain D
residue 263
type
sequence R
description binding site for residue KJP D 400
source : AC4

60) chain D
residue 267
type
sequence L
description binding site for residue KJP D 400
source : AC4

61) chain D
residue 270
type
sequence F
description binding site for residue KJP D 400
source : AC4

62) chain D
residue 271
type
sequence G
description binding site for residue KJP D 400
source : AC4

63) chain D
residue 294
type
sequence I
description binding site for residue KJP D 400
source : AC4

64) chain A
residue 194
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
source Swiss-Prot : SWS_FT_FI1

65) chain A
residue 197
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
source Swiss-Prot : SWS_FT_FI1

66) chain B
residue 194
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
source Swiss-Prot : SWS_FT_FI1

67) chain B
residue 197
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
source Swiss-Prot : SWS_FT_FI1

68) chain C
residue 194
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
source Swiss-Prot : SWS_FT_FI1

69) chain C
residue 197
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
source Swiss-Prot : SWS_FT_FI1

70) chain D
residue 194
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
source Swiss-Prot : SWS_FT_FI1

71) chain D
residue 197
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
source Swiss-Prot : SWS_FT_FI1

72) chain A
residue 253-272
type prosite
sequence VFSDGVTNWGRIVTLISFGA
description BH1 Apoptosis regulator, Bcl-2 family BH1 motif signature. VFsDGvtNWGRIVTLIsFGA
source prosite : PS01080

73) chain A
residue 305-316
type prosite
sequence WLVKQRGWDGFV
description BH2 Apoptosis regulator, Bcl-2 family BH2 motif signature. WLvkqRGWDgFV
source prosite : PS01258

74) chain A
residue 209-223
type prosite
sequence ALETLRRVGDGVQRN
description BH3 Apoptosis regulator, Bcl-2 family BH3 motif signature. AletLRrVGDGVQRN
source prosite : PS01259


Display surface

Download
Links